Kosmidis, M.L. Pikazis, D. Vlachoyiannopoulos, P. Tzioufas, A.G. Dalakas, M.C., Trial of canakinumab, an IL-1β receptor antagonist, in patients with inclusion body myositis, Neurology® Neuroimmunology and Neuroinflammation, (6), 2019, Lippincott Williams and Wilkins, 2332-7812